Okay, let's tackle this question about oral vancomycin. The question is asking which condition it can treat. First, I need to recall the pharmacology of vancomycin. Vancomycin is a glycopeptide antibiotic, right? It's typically used for Gram-positive bacteria.

Wait, but the question is about oral administration. I remember that vancomycin isn't absorbed well when taken orally, so it's used for local action in the gut. That makes sense because if it's not absorbed, it can target infections in the gastrointestinal tract. The main indication I remember is for Clostridioides difficile infection, which causes pseudomembranous colitis. Oral vancomycin is given to kill the C. difficile in the colon without systemic absorption.

Now, the options aren't listed, but the correct answer is likely C. difficile. Let me think about other options that might be distractors. Maybe other infections like MRSA, but MRSA is usually treated with IV vancomycin. Or maybe something like a skin infection, but oral vancomycin isn't effective there. Another possible distractor could be tuberculosis, but that's not relevant here. Or maybe a urinary tract infection, but again, vancomycin isn't used for UTIs.

Wait, another point: oral vancomycin is sometimes used for severe C. difficile infections that don't respond to metronidazole. Also, it's not used for systemic infections because it's not absorbed. So the key here is the localized action in the gut for C. difficile. The other options would probably involve systemic infections where oral vancomycin isn't effective because it doesn't get into the bloodstream.

Let me check if there are other uses. Sometimes, vancomycin is used for antibiotic-associated colitis or pseudomembranous colitis, which are both caused by C. difficile. So the correct answer is definitely related to that. The distractors might include other bacterial infections where vancomycin is used IV, like MRSA or endocarditis, but those aren't applicable orally. Also, maybe something like a fungal infection, but vancomycin is not antifungal.

So the core concept here is the pharmacokinetics of vancomycin—its poor oral absorption leading to use in gut infections. The correct answer is C. difficile infection. The other options would be incorrect because they either require systemic absorption or are not caused by bacteria that vancomycin targets.

**Core Concept**
Oral vancomycin is a **glycopeptide antibiotic** with **minimal systemic absorption**, making it effective for **localized gastrointestinal infections**, particularly **Clostridioides difficile** (C. difficile) colitis. It binds to **D-alanyl-D-alanine** in cell wall precursors of Gram-positive bacteria, inhibiting cell wall synthesis.

**Why the Correct Answer is Right**
The correct answer is **Clostridioides difficile infection**. Oral vancomycin acts locally in the gastrointestinal tract to eradicate C. difficile overgrowth caused by prior antibiotic use. It achieves high concentrations in the colon, targeting the pathogen without systemic effects. This is critical because C. difficile produces toxins that cause pseudomembranous colitis, and oral vancomycin is first-line for severe or recurrent cases.

**Why Each Wrong Option is Incorrect**
**Option A:** *MRSA skin infections* – Incorrect.

✓ Correct Answer: B. Pseudomembranous colitis